首页> 美国卫生研究院文献>Case Reports in Gastroenterology >Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation
【2h】

Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation

机译:α-胎儿蛋白产生早期胃癌肝脏肝癌和胎儿肠溶分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alpha-fetoprotein (AFP)-producing gastric carcinomas (AFPGCs) are relatively rare tumors known to have a poor prognosis and commonly found as advanced lesions. Histologically, AFPGCs have been described as having hepatoid and fetal enteric (enteroblastic) morphology and are associated with conventional adenocarcinomas. Prior studies reported a hepatoid component present only in invasive areas and hypothesized that AFPGCs may develop hepatoid features during the process of tumor invasion. We report three cases of AFP-producing early gastric cancer which had an intramucosal hepatoid component. Immunohistochemistry showed that the hepatoid component was diffusely immunoreactive for SALL4, AFP, arginase-1, and HepPar1, and focally for CDX2 and PDX1. An intramucosal transition between the hepatoid component and conventional intramucosal adenocarcinoma was identified. Two patients also had a coexistent fetal enteric component, which was admixed with a hepatoid component. Although at an early stage one patient subsequently developed liver metastasis and a second patient was suspected of having liver metastasis, these were not biopsy-proven. The latter patient had a previous history of hepatocellular carcinoma (HCC) and SALL4 was used on the HCC to distinguish metastatic/further HCC from a gastric metastatic primary with hepatoid differentiation.
机译:α-胎儿(AFP) - 胃癌癌(AFPGC)是相对罕见的肿瘤,已知具有差的预后和常见于晚期病变。组织学上,已被描述为具有肝异肠和胎儿肠道(肠溶细胞)形态并且与常规腺癌有关。事先研究报告仅在侵袭性区域存在肝异质组分,并假设AFPGC在肿瘤侵袭过程中可能会出现肝异性特征。我们报告了三种患有AFP的早期胃癌患者,该肝癌具有鉴别肝固醇组分。免疫组织化学表明,肝固醇组分对于SALL4,AFP,氨基酶-1和HePPAR1弥漫性免疫反应,致谱称用于CDX2和PDX1。鉴定了肝异化组分与常规鉴别腺癌之间的腔内转变。两名患者还具有共存的胎儿肠溶组分,其与肝固定组分混合。尽管在早期阶段,一名患者随后发育肝脏转移,并且怀疑患有肝脏转移的第二患者,这些不是活组织检查证明。后一种患者具有先前的肝细胞癌(HCC)和SALL4的历史,并且在HCC上使用SALL4以通过肝异化分化区分从胃转移初级的转移性/其他HCC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号